HEALTHPEAK (DOC) director Ava Lias-Booker receives 9,744-share RSU grant

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Lias-Booker Ava reported acquisition or exercise transactions in this Form 4 filing.

HEALTHPEAK PROPERTIES, INC. director Ava Lias-Booker received an equity grant of 9,744 shares of Common Stock as a compensation award. Following this grant, she directly holds 45,305 shares. The award consists of restricted stock units that vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company’s next annual meeting of stockholders.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lias-Booker Ava

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	9,744	$0.00	--

Holdings After Transaction: Common Stock — 45,305 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Equity grant size: 9,744 shares Holdings after grant: 45,305 shares Transaction price per share: $0.0000

3 metrics

Equity grant size 9,744 shares Restricted stock unit award on May 6, 2026

Holdings after grant 45,305 shares Total Common Stock directly held after transaction

Transaction price per share $0.0000 Indicates non-cash equity compensation grant

Key Terms

Restricted stock units, grant date, annual meeting of stockholders

3 terms

Restricted stock units financial

"Restricted stock units vest in full on the earlier of the first anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

grant date financial

"the first anniversary of the May 6, 2026 grant date or the Company's"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

annual meeting of stockholders financial

"or the Company's next annual meeting of stockholders."

Form 4 Insider Transactions: What Each Field Means →

05/07/2026 - 08:08 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lias-Booker Ava

(Last)

(First)

(Middle)

4600 SOUTH SYRACUSE STREET

SUITE 500

(Street)

DENVER

COLORADO

80237

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHPEAK PROPERTIES, INC. [ DOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/06/2026		A		9,744⁽¹⁾	A	$0	45,305	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company's next annual meeting of stockholders.

Remarks:

	Carol Samaan, SVP, Legal (Attorney-In-Fact)	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Ava Lias-Booker report in the HEALTHPEAK (DOC) Form 4 filing?

Ava Lias-Booker reported receiving a grant of 9,744 shares of HEALTHPEAK Common Stock as an equity award. These shares are in the form of restricted stock units that vest based on time and the company’s next annual stockholder meeting.

How many HEALTHPEAK (DOC) shares does Ava Lias-Booker hold after this transaction?

After the reported grant, Ava Lias-Booker directly holds 45,305 shares of HEALTHPEAK Common Stock. This total reflects the newly awarded 9,744-share restricted stock unit grant added to her prior holdings as disclosed in the Form 4 filing.

What type of transaction is disclosed in the HEALTHPEAK (DOC) Form 4 for Ava Lias-Booker?

The Form 4 shows a grant, award, or other acquisition of 9,744 shares coded as “A.” This is a non-cash equity compensation event rather than an open-market purchase or sale, and is classified as an acquisition of Common Stock through restricted stock units.

When do Ava Lias-Booker’s restricted stock units in HEALTHPEAK (DOC) vest?

The restricted stock units vest in full on the earlier of two dates: the first anniversary of the May 6, 2026 grant date or the company’s next annual meeting of stockholders. This creates a time-based vesting schedule tied to governance events.

Was there a purchase price for the HEALTHPEAK (DOC) shares granted to Ava Lias-Booker?

The Form 4 reports a transaction price per share of $0.0000 for the 9,744 shares. This indicates the shares were granted as part of equity compensation, not bought in the open market, so no cash was paid by the director for this award.

Is the Ava Lias-Booker Form 4 for HEALTHPEAK (DOC) a buy or a sell transaction?

The filing reflects an acquisition through an equity grant, not a sale. It is categorized as a grant, award, or other acquisition of 9,744 shares of Common Stock via restricted stock units, increasing her direct holdings to 45,305 shares.